One in 10 Medicare Advantage enrollees were forced to disenroll from their health plan heading into 2026 due to insurer exits from the market — a tenfold increase from historical averages. The three largest MA payers made dramatic cuts to their footprints:
| Payer | States Dropped | Counties Dropped | Key Changes |
|---|---|---|---|
| UnitedHealthcare | 1 state | 109 counties | Dropped most remote patient monitoring coverage effective January 2026 |
| Humana | 3 states | 194 counties | Reduced OTC benefits for special needs plans |
| Aetna | 1 state | 100 counties | Cut allowances for OTC health/wellness items in non-SNP plans |
These cuts are a direct response to a 20% decline in government reimbursement from 2023 to 2026 levels. At the same time, payers raised deductibles, increased out-of-pocket maximums, and trimmed previously standard benefits to preserve margins.
Cigna exited the Medicare Advantage market entirely in 2024, signaling the severity of the financial pressure on MA plan operations.
Expect authorization delays and denials to increase. Payers under financial pressure intensify prior authorization requirements, documentation scrutiny, downcoding, and post-payment audits to reduce spend. Verify patient eligibility and benefits at every encounter — plan changes are creating gaps in coverage that patients may not yet understand.
Practices should expect heightened payer scrutiny across all MA plans in 2026. Front-end eligibility verification has never been more critical. 71% of providers now cite real-time insurance verification as their primary daily challenge.
CMS began Payment Year 2020 RADV (Risk Adjustment Data Validation) audits in February 2026, implementing an accelerated schedule that will audit all eligible MA plans annually with new audits initiated approximately every three months.
Each diagnosis submitted for risk adjustment must meet specific requirements:
Plans may submit up to two medical records per audited condition, but CMS only needs one valid record to support the diagnosis and payment. The five-month medical record submission window has been restored.
CMS announced it will use artificial intelligence as a support tool for medical coders during RADV audits. However, AI will support — not replace — human-certified medical coders, and all coding decisions affecting overpayments will be made by humans.
If you provide services to Medicare Advantage patients, expect documentation requests from MA plans conducting internal validation before CMS audits. Common issues that trigger denials:
Review your encounter documentation templates now. Ensure every chronic condition carries forward with supporting clinical evidence and examination findings at each visit, not just in the assessment/plan.
More than 70% of health systems plan to expand AI-driven automation in their revenue cycle by 2026, with autonomous medical coding at the top of the priority list, according to Black Book Research.
Traditional AI coding tools make suggestions that human coders review and approve. Autonomous coding platforms code the complete chart and send it directly to billing with no human approval and no validation queue.
The technology shift in 2026 is the rise of agentic AI — platforms that operate like an AI employee, autonomously reviewing charts, extracting clinical details, and assigning codes with clear explanations.
Early adopters report:
Autonomous coding is no longer experimental — it's becoming the competitive standard. Practices not evaluating these platforms risk falling behind on both efficiency and accuracy benchmarks.
The ICD-10-CM Official Guidelines for Coding and Reporting were updated for fiscal year 2026, effective October 1, 2025. Key changes include:
BMI Coding Restriction
"BMI codes should only be assigned when there is an associated, reportable diagnosis (such as obesity or anorexia) documented by the patient's provider." Standalone BMI codes without a linked diagnosis are no longer compliant.
HIV Coding Revision
In FY 2026, assign Z21 (asymptomatic HIV) for HIV-positive patients being treated with antiretroviral medication "in the absence of any additional documentation of HIV disease, HIV-related illness or AIDS."
Type 2 Diabetes in Remission
A new code E11.A (Type 2 diabetes mellitus without complications in remission) should be assigned when the provider's documentation indicates the diabetes mellitus is in remission. This aligns coding with clinical reality for patients achieving remission through lifestyle or pharmaceutical intervention.
Multiple Sites Guidance
ICD-10-CM added new guidance defining "multiple sites." Coders should follow chapter-specific guidelines for assigning codes for multiple sites. If there are no chapter-specific guidelines, assign codes for individual sites when documented. If specific sites are not documented, assign the code for multiple sites.
Thoracic Endovascular Aortic Repair (33880–33886)
This code family was extensively revised. Codes now apply to the entire thoracic aorta, not just the descending thoracic aorta. Three codes deleted (33884, 33889, 33891), four revised (33880, 33881, 33883, 33886), and one new code added (33882). Immediate coder retraining required for radiology and interventional practices.
These guideline changes affect how you code common conditions. Verify your coding team has updated workflows for BMI, diabetes remission, and the revised thoracic aorta procedures.
Denial management is undergoing a strategic transformation. The focus is moving upstream, with AI-driven denial risk scoring models flagging claims with greater than 70% denial risk before submission. This prevents denials rather than chasing them after they occur.
Nearly two-thirds of surveyed RCM leaders identified denials and underpayments as their single largest barrier to revenue growth in 2026, reflecting a shift from operational challenges to payer-driven financial pressure.
Traditional denial management is reactive: submit claim → receive denial → appeal. The 2026 model is proactive:
The CMS Interoperability & Prior Authorization Rule goes live in 2026, requiring payers to respond faster and use APIs. Providers not equipped for electronic prior authorization risk denials for "non-compliant submissions."
Payers under financial pressure will intensify downcoding, prior authorization requirements, and documentation scrutiny in 2026. Analysis shows denial activity increasingly occurs outside traditional remittance reporting and extends months beyond payment.
The industry standard for clean claim rates is 98%, but performance varies dramatically across practices. Some organizations achieve an impressive 99.9% clean claim rate, while others struggle to exceed 90%.
Research shows that claim scrubbing saves practices $25 per claim, and practices using scrubbing software see 50% fewer denials. Clean claims get paid 3 times faster than ones with errors.
For a practice submitting 1,000 claims per month:
The difference between 90% and 99% clean claims is $27,000 annually in direct rework costs, plus the revenue cycle velocity loss from delayed payments.
1. Implement AI-Powered Claim Scrubbing
Properly implemented claim scrubbing technology ensures a minimum 95% first-pass clean claim acceptance rate. AI combined with human oversight has transformed medical coding accuracy.
2. Integrate EHR and Billing Systems
Integration minimizes errors, speeds up clean claim submission, and boosts compliance, cash flow, and transparency.
3. Develop Consistent Templates
Standardized templates for patient registration and charge capture reduce variability and error rates.
4. Train Staff on Scrubbing Software
Train all billing staff on scrubbing software features, teach staff how to interpret and fix errors, and provide ongoing education when software updates or changes occur.
5. Double-Check Demographics and Insurance
The majority of denials stem from front-end errors: incorrect patient information, outdated insurance details, missing authorizations.
Organizations using automated claim scrubbing report:
The clean claim rate gap between top performers and average performers is driven by technology adoption and front-end discipline. Moving from 90% to 98% clean claims can generate six-figure annual savings for mid-sized practices.
KLAS Research released its annual "Best in KLAS" report on February 4, 2026, ranking healthcare technology vendors and service providers across more than 140 market segments based on feedback from clinicians and administrators.
The highest-performing vendors for end-to-end RCM outsourcing in 2026:
| Vendor | Overall Performance Score | Client Satisfaction Highlights |
|---|---|---|
| Ensemble | 95.1 / 100 | Highest client satisfaction across all metrics |
| Guidehouse | 93.8 / 100 | Strong execution and client outcomes |
| Optum | 61.9 / 100 | Mid-tier performance |
| R1 RCM | 55.6 / 100 | Clients report low satisfaction due to long-standing issues and slow execution |
KLAS 2026 evaluated vendors across multiple revenue cycle segments:
Ensemble and Guidehouse dominate the end-to-end outsourcing market with client satisfaction scores 35–40 points higher than R1 RCM, the largest RCM vendor by market share. This gap illustrates that size does not guarantee performance.
Prior Authorization Technology is now recognized as a distinct category in KLAS rankings, reflecting the market's recognition that PA workflow automation is mission-critical infrastructure, not an optional add-on.
Vendor selection should prioritize client satisfaction and execution quality over brand recognition. The performance gap between top-tier and bottom-tier vendors exceeds 30 points — a gap that translates directly to revenue cycle outcomes.